Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.
Shen Y, Li J, Nitta M, Futalan D, Steed T, Treiber JM, Taich Z, Stevens D, Wykosky J, Chen HZ, Carter BS, Becher OJ, Kennedy R, Esashi F, Sarkaria JN, Furnari FB, Cavenee WK, Desai A, Chen CC.
Shen Y, et al. Among authors: taich z.
Oncotarget. 2015 May 20;6(14):11751-67. doi: 10.18632/oncotarget.3996.
Oncotarget. 2015.
PMID: 26059434
Free PMC article.